Figure 1.

Improvement of metabolic control by stem cell educator therapy. (A) Twelve-week follow-up of HbA1C levels in T2D subjects. (B) Analysis of insulin sensitivity by HOMA-IR C-peptide at four weeks post-treatment with Stem Cell Educator therapy. (C) 56-week follow-up C-peptide levels in Group C T2D subjects with impaired islet β cell function. (D) Analysis of islet β cell function by HOMA-B C-peptide at 12-week follow-up post-treatment with Stem Cell Educator therapy in Group C T2D subjects.

Zhao et al. BMC Medicine 2013 11:160   doi:10.1186/1741-7015-11-160
Download authors' original image